Clinical Trial Update: Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating OSE-127 versus placebo in moderate to severe active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• OSE-127

Snippet

Sponsor: OSE Immunotherapeutics | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED